1 – 20 of 30
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors
(
- Contribution to journal › Article
- 2019
-
Mark
Durable response to mTOR inhibition in a patient with relapsing papillary tumor of the pineal region
(
- Contribution to journal › Article
-
Mark
Neurologic disorders in 4858 survivors of central nervous system tumors in childhood-an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study
(
- Contribution to journal › Article
- 2016
-
Mark
Development after pediatric brain tumor-a longitudinal study
(
- Contribution to journal › Article
- 2015
-
Mark
Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis.
(
- Contribution to journal › Article
-
Mark
Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma.
(
- Contribution to journal › Article
-
Mark
TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas.
(
- Contribution to journal › Article
- 2014
-
Mark
Comparison of neuropsychological and brain imaging data in pediatric brain tumor patients surviving more than 10 years
2014) 16th International Symposium on Pediatric Neuro-Oncology In Neuro-Oncology 16(Suppl 1). p.99-104(
- Contribution to journal › Article
-
Mark
Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer.
(
- Contribution to journal › Article
-
Mark
Sequencing IDH1/2 glioma mutation hotspots in gliomas and malignant peripheral nerve sheath tumors.
(
- Contribution to journal › Letter
- 2013
-
Mark
Subsequent brain tumors in patients with autoimmune disease.
(
- Contribution to journal › Article
-
Mark
Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1.
(
- Contribution to journal › Article
- 2012
-
Mark
ANALYSIS OF CLUSTER OF DIFFERENTIATION (CD) MARKERS IN PEDIATRIC BRAIN TUMORS CAN BE USED AS A DIAGNOSTIC AND PROGNOSTIC TOOL
2012) 15th International Symposium on Pediatric Neuro-Oncology In Neuro-Oncology 14(suppl. 1). p.43-48(
- Contribution to journal › Published meeting abstract
-
Mark
Estimated clinical benefit of protecting neurogenesis in the developing brain during radiation therapy for pediatric medulloblastoma.
(
- Contribution to journal › Article
- 2010
-
Mark
Plant thymidine kinase 1: a novel efficient suicide gene for malignant glioma therapy.
(
- Contribution to journal › Article
-
Mark
THE USE OF GAMMA-KNIFE SURGERY IN PALLIATIVE CARE OF RELAPSING EPENDYMOMAS WITH DURABLE QUALITY OF LIFE
(
- Contribution to journal › Published meeting abstract
-
Mark
COGNITIVE LATE COMPLICATIONS AFTER PEDIATRIC BRAIN TUMOR IN A CLINICAL SAMPLE RELATED TO PREDICTING FACTORS
(
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors
(
- Contribution to journal › Article
- 2008
-
Mark
Tumor Specific Migration Of Bone-Marrow Derived Rat Mesenchymal Stem Cells In The Invasive N29 Rat Brain Tumor Model
2008) 8th Congress of the European-Association-for-Neuro-Oncology (EANO) In Neuro-Oncology 10(6). p.1066-1066(
- Contribution to journal › Published meeting abstract
-
Mark
Distribution Of Inos In Rat Experimental Glioma
2008) 8th Congress of the European-Association-for-Neuro-Oncology (EANO) In Neuro-Oncology 10(6). p.1114-1114(
- Contribution to journal › Published meeting abstract